Stories from Aachen

FEV Group

FEV and ProLogium develop high-performance vehicle battery

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Fraunhofer-Institut für Produktionstechnologie IPT

2

Deep learning for real-time quality control: Aachen-based Fraunhofer Institutes improve defect detection in weld seams

P3 Automotive GmbH

Google Recognizes P3 as Accredited Android™ Automotive 3PL Vendor for AAOS Compliance/xTS

Grünenthal Group

Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer